← Back to Search

Behavioural Intervention

Relaxation Control Condition for Obsessive Hoarding (Exercise BDNF Trial)

N/A
Waitlist Available
Led By Hannah Levy, PhD
Research Sponsored by Hartford Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Primary diagnosis of hoarding disorder
* Age 45-65 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after the intervention or control condition
Awards & highlights

Summary

Hoarding disorder (HD) is characterized by difficulty discarding personal possessions due to significant emotional distress when parting with personal items. This leads to the accumulation of excessive clutter which compromises the normal use of living spaces. In addition to emotional distress, individuals with HD experience significant impairment in physical health. One study found an 11-fold increase in stroke risk, a 10-fold increase in cancer risk, and a 7-fold increase in cardiovascular disease in individuals with HD relative to a general population comparison group. Patients with HD are also more likely to experience obesity and metabolic diseases such as diabetes. The short-term goal of the proposed study is to determine whether a brief exercise intervention improves discarding-related distress and brain-derived neurotropic factor (BDNF) in individuals with HD relative to a relaxation control condition. Preliminary evidence suggests that BDNF may be associated with greater body mass index and more severe HD symptoms in patients with HD. BDNF is a well-studied growth factor which is involved in neuronal transmission, plasticity, and survival of many neuron systems that have been implicated in psychiatric disorders, including serotonin, glutamate, and dopamine. BDNF has been proposed as a mechanism of exercise interventions for psychiatric disorders, as even one session of exercise has been shown to increase BDNF levels. This study represents an initial first step towards the long-term goal of improving current treatments for HD. This is important because although current cognitive-behavioral treatments (CBT) are effective, only 35% of patients who receive these treatments actually benefit from them. In the proposed pilot study, the investigators will test whether 30 minutes of moderate-intensity exercise reduces the distress associated with discarding and increases BDNF levels in individuals with HD relative to a relaxation control. The investigators will recruit 22 individuals with a primary diagnosis of HD. They will be randomly assigned to exercise or control. Following the intervention, the investigators will assess BDNF via serum. Participants will complete a standardized discarding task which consists of sorting and discarding personal possessions. The central hypothesis is that those in the exercise condition will demonstrate lower distress during the discarding task and greater BDNF levels as compared to those in the relaxation control condition. Should the hypothesis be confirmed, the investigators will be well poised to conduct large-scale clinical trials testing exercise interventions as adjunctive or alternative treatments to standard CBT.

Who is the study for?
This trial is for individuals with Hoarding Disorder (HD), characterized by difficulty discarding possessions and cluttered living spaces. Participants should have a primary diagnosis of HD to join the study, which aims to explore if exercise can help reduce distress associated with discarding items.
What is being tested?
The study tests whether a brief, 30-minute moderate-intensity exercise session can lower the emotional distress linked to throwing away possessions in people with HD compared to a relaxation control group. It also examines if this physical activity increases levels of BDNF, a protein potentially connected to HD severity.
What are the potential side effects?
Since the intervention involves moderate exercise or relaxation techniques, side effects are expected to be minimal. However, typical risks associated with moderate physical activity may include muscle soreness or strain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~experimenter will tally the number of items kept vs. discarded immediately after the discarding task
This trial's timeline: 3 weeks for screening, Varies for treatment, and experimenter will tally the number of items kept vs. discarded immediately after the discarding task for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Brain Derived Neurotropic Factor (BDNF)
Subjective Units of Distress Scale
Secondary study objectives
Number of items discarded

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Relaxation Control ConditionExperimental Treatment1 Intervention
For participants randomized to the control group, they will sit in the testing room and watch informational videos about animals.
Group II: Exercise ConditionActive Control1 Intervention
For participants randomized to the exercise intervention, they will complete 30 minutes of brisk walking around the campus. They will be asked to maintain at least a moderate level of exercise intensity throughout the 30-minute walk.

Find a Location

Who is running the clinical trial?

Hartford HospitalLead Sponsor
136 Previous Clinical Trials
19,086 Total Patients Enrolled
University of MiamiOTHER
928 Previous Clinical Trials
413,586 Total Patients Enrolled
Hannah Levy, PhDPrincipal InvestigatorHartford Hospital
~15 spots leftby Dec 2025